Control of arterial pressure in patients undergoing anti-hypertensive treatment in Brazil - Controlar Brazil;Controle da pressão arterial em pacientes sob tratamento anti- hipertensivo no Brasil - Controlar Brasil

Arquivos Brasileiros de Cardiologia

Volumn 94, Issue 5, 2010, Pages 663-670

  Nobre, Fernando ^a   Ribeiro, Artur Beltrame ^b   Mion Jr , Décio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DO RIM E HIPERTENSÃO   (Brazil)

Author keywords

Antihypertensive agents therapeutic use; Blood pressure drug effects

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BRAZIL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PROTEINURIA; RISK FACTOR; SMOKING; TREATMENT DURATION; WAIST CIRCUMFERENCE;

EID: 77953759644     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000035     Document Type: Article

References (22)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289 (19): 2560-72.
2. Lewington S, Clarke R, Chizibash N, Peto R, Collins R. Prospective Study Collaboration. Age specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet. 2002; 360 (14): 1903-13.
3. Mion Jr D, Kohlmann Jr O, Machado CA, Amodeo C, Gomes MAM, et al. Sociedade Brasileira de Cardiologia / Sociedade Brasileira de Hipertensão. V Diretrizes brasileiras de hipertensão. Rev Bras Hipertens. 2006; 14 (4): 257-306.
4. Wolf-Mayer K, Cooper RS, Kramer HB, Banegas JR, Giampaoli S, Joffres MR, et al. European hypertension treatment and control in five countries, Canada and United States. Hypertension. 2004; 43 (1): 10-7.
5. Turnbull F. Blood Pressure Control Lowering Treatment Trialist' Collaboration: Effects of different blood-pressure-lowering regimes on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet. 2003; 362 (9395): 1527-35.
6. Williams B. The year of hypertension. J Am Coll Cardiol. 2006; 48 (8): 1698-711.
7. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the HOT (Hypertension Optimal Study) randomized trial. Lancet. 1998; 351 (9118): 1755-62.
8. Mancia G, Backer G, Dominiczak A, Cifkova R, Heagesty AM, Kjeldsen SE, et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25 (6): 1105-87.
9. Borzechi AM, Wong AT, Hickey E , Berlowitz DR. Hypertension control - how well are we doing? Arch Intern Med. 2003; 163 (22): 2705-11.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42 (6): 1206-52.
11. Pereira MR, Coutinho MSSA, Freitas PF, D'Orsi E, Benardi A, Hass R. Prevalência, conhecimento, tratamento e controle de hipertensão arterial sistêmica na população adulta urbana de Tubarão, Santa Catarina, Brasil, em 2003. Cad Saúde Pública. 2007; 23 (10): 2363-74.
12. Mion Jr D. Hipertensão arterial. [Acesso em 2009 jun 23]. Disponível em: WWW.deciomion.com.br
13. Nobre F, Silva CP, Lima NKC, Santos LAC, Veiga EV, Nogueira MS, et al. Características e resultados do atendimento de pacientes na Unidade de Hipertensão do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. Rev Bras Med. 2000; 57 (7): 694-708.
14. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002; 20 (8): 1461-4. (Pubitemid 34921162)
15. Ma J, Stafford RS. Screening, treatment, and control of hypertension in US private physician offices, 2003-2004. Hypertension. 2008; 51 (5): 1275-81.
16. McInnis NH, Fodor G, Moy Lum-Kwong M, Leenen FH. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP). Am J Hypertens. 2008; 21 (11): 1210-5.
17. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. The BHS guidelines working party, for the British Hypertension Society. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004; 328 (7440): 634-40.
18. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension - Guidelines Committee. J Hypertens. 2003; 21 (6): 1011-53.
19. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364 (9438): 937-52.
20. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 Diabetes. N Engl J Med. 2008; 359 (15): 1565-76.
21. Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Levey AS, Milas NC, et al. Achievement and safety of a low blood pressure goal in chronic renal disease: the Modification of Diet in Renal Disease Study Group. Hypertension. 1997; 29 (2): 641-50. (Pubitemid 27074731)
22. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens (Greenwich). 2008; 10 (8): 644-6.